FCC ID: 2BCAP000001 MasterX 800 Series Wireless/Wired X-Ray Flat Panel Detector

FCC ID:2BCAP000001 FCC ID:2BCAP000001 FCC ID:2BCAP000001 FCC ID:2BCAP000001 FCC ID:2BCAP000001 FCC ID:2BCAP000001

Grantee also Agent for Service of Process_FCC_Attestation Statements_Kiwa RF_754_02 15-02-2023 U.S. Agent Designation for Service of Process

(Applicant is Both Grantee and U.S. Agent) TO:

Kiwa Nederland B.V. Wilmersdorf 50 7327 AC Apeldoorn Postbus 137 7300 AC Apeldoorn Netherlands ATTENTION: FCC Certification Section 2.911(d)(7) Information This letter is to confirm that the Applicant will also serve as the U.S. Agent for Service of Process as required by 47 CFR 2.911(d)(7). The Applicant acknowledges that they must maintain an agent for no less than one year after terminating all marketing and importation OR the conclusion of any Commission-related proceeding involving the equipment. The Applicant further acknowledges their responsibility to inform the FCC whenever the Designated U.S. Agent information changes. Medicatech USA 0034063842 2BCAP George Makar Medicatech USA 50 Maxwell, Irvine, California 92618, United States 92618

(949) 679-2881 george@medicatechusa.com Applicant & Agent Company name:

FRN:

Grantee Code:

Contact person name:

Agent name:

Street address:

ZIP/City/State Telephone number:

Email address:

Signature Contact person*:

Date:

Signature Agent*:

Date:

10/08/202310/08/2023

Covered list attestation FCC application letter Kiwa Page | of 2 RF_755_02 15-02-2023 Medicatech USA Certification Application Attestation Statements Medicatech USA 50 Maxwell, Irvine, California 92618, United States Subject: FCC ID: 2A77600002 To Whom It May Concern:

Statement for 47 CFR section 2.91 4(d)(5)(i)

[Medicatech USA] certifies that as of the date of the application the equipment for which authorization is sought is not covered equipment prohibited from receiving an equipment authorization pursuant to section 2.903 of the FCC rules. If the equipment for which the applicant seeks authorization is produced by any of the entities identified on the current Covered List, including affiliates or subsidiaries of the named companies, the applicant must include an explanation on why the equipment is not covered equipment. Additional Explanation: <N/A>

Statement for 47 CFR section 2.911(d)(5)(ii)

[Medicatech USA] (the applicant) certifies that, as of the date of the filing of this application, the applicant

-is/O-is not identified on the Covered List as an entity producing covered equipment. Date: 8/11/2023 City: California Name : George Makar Function: President Telephone number: (949) 679-2881 Email address: george@medicatechusa.com l=

Signature: A Yw

+~ The Commissions Covered List is published by the Public Safety and Homeland Security Bureau and posted on the Commission's website. This Covered List, which is Periodically updated, identifies particular equipment, produced by particular entities, that constitutes covered equipment. https://www.fcc.gov/supplychain/coveredlist .

(2): For FCC it must be the Grantee Code owner or the authorized agent.

(3): double click on the appropriate box and select checked then OK

Date: August 11, 2023 Federal Communications Commission 7435 Oakland Mills Road Columbia, Maryland 21046 USA SUBJECT: Change of Identification Authorization To Whom It May Concern:

This letter grants authorization for representatives of Medicatech USA to apply to the FCC fora change in identification as specified under 47CFR2.933 of the FCC rules. This authorization applies to the InnoCare Optoelectronics Corp, FCC ID: 2AS4N000002, grant date: 01/19/2023. We are aware that Medicatech USA intends to market the above referenced product under their FCC ID: 2BCAP00000]

Sincerely, Sean blane Original Grantee contact: Sean Liang Date: August 11, 2023 Function: PM Director Department: PM E-mail: Sean. YS. Liang@innocare-x.com

Date: 8/11/2023 Federal Communications Commission 7435 Oakland Mills Road Columbia, Maryland 21046 USA SUBJECT: Change of Identification Authorization To Whom It May Concern:

The purpose of this letter is to apply for a change in identification as specified under 47CFR2.933 of the FCC rules, based on the original FCC ID: 2AS4N000002, grant date: 01/19/2023. 1. 2. 3. The equipment bearing the modified FCC ID: 2BCAP000001 is electrically identical to original equipment, there is no change in design, circuitry or construction. The original test results continue to be representative of and applicable to the equipment bearing the changed identification. The original software security exhibit showing this device meets the requirements of KDB 594280 continue to be representative of and applicable to the equipment bearing the changed identification. 4. As new grantee, we, Medicatech USA, responsible for changes to the device and will not alter or offer any capabilities that will modify DFS settings. Sincerely, New Grantee contact:

Printed Name / Title: George Makar / President Company: Medicatech USA E-mail: george@medicatechusa.com Tel: (949) 679-2881

Federal Communications Commission Authorization and Evaluation Division 1435 Oakland Mills Road Columbia, MD 21046 Date: August 23, 2022 SUBJECT: FCC Application for 2BCAP000001 To Whom It May Concern:

We, the undersigned, hereby authorize Kevin Tsai at SGS Compliance Certification Services Inc. on our behalf, to apply to the Federal Communications Commission on our equipment. Any and all acts carried out by SGS Compliance Certification Services Inc. on our behalf shall have the same effect as acts of our own. This is to advise that we are in full compliance with the Anti- Drug Abuse Act. We, the applicant, are not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 USC853a, and no party to the application is subject to a denial of federal benefits pursuant to that section. Regards, ____________________________

(Printed Name) George Makar

(Must be signed by the person that is listed on the FCC Website) M:\Master Documents\TEMPLATES\POA_Letter.doc